The increase in operating expense compared to the prior year period was primarily driven by investments in our selling and marketing organization, public company costs, which did not impact the prior year period results, and the resumption of discretionary spending, including travel and related expenses given the more normalized business environment as compared to the significant cost reduction efforts in the prior year period as a result of the COVID-19 pandemic, as well as operating expenses related to our acquisition of Bioness, which did not impact the prior year period.

Aug 10, 2021 / CFO / receipt, needs a key / Greg Englund, CFO | earnings call 2021-08-10 | transcript 52fe2725-7a06-4648-a3d6-cdd54195d6c2 | chars 18262-18843 | segment 18